{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:51:20Z","timestamp":1791496280330,"version":"4.3.4"},"reference-count":151,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T00:00:00Z","timestamp":1656115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T00:00:00Z","timestamp":1656115200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100007446","name":"King Khalid University","doi-asserted-by":"publisher","award":["RGP.1\/173\/43"],"award-info":[{"award-number":["RGP.1\/173\/43"]}],"id":[{"id":"10.13039\/501100007446","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Cosmetic Dermatology"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Vitiligo is a depigmenting illness that causes white areas on the skin. Vitiligo's pathogenetic genesis is based on the melanocyte's autoimmune destruction, in which oxidative stress causes melanocyte molecular, organelle, and exposure of antigen, as well as melanocyte cell death, and so plays a role in vitiligo progression. Natural compounds have recently shown a wide range of therapeutic bioactivities against a number of skin disorders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>The aim of this work is drug delivery of natural products through nano\u2010carriers for effective vitiligo therapy: A compendia review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods &amp; Materials<\/jats:title>\n                    <jats:p>An online literature analysis was guided for vitiligo therapy, nanotechnology, phytochemical composition, and, types of vitiligo, types of nanomedicine. Appropriate information were taken from different electronic scientific databases such as Web of Science, Science Direct, Elsevier, Google Scholar, Springer, PubMed, and scripts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Nano\u2010carriers\u2010based natural compounds provide a great relationship for the enhancement in the efficacy and safety of pharmacotherapeutic agents for the treatment of vitiligo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>In this study focuses on natural compounds' effects and processes on vitiligo models. Although topical therapy plays an important role in vitiligo treatment, its utility and patient compliance are hampered by adverse effects or inadequate efficacy. Novel drug delivery techniques can help improve topical medication delivery by improving epidermal localization, reducing side effects, and increasing effectiveness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This paper covers the significant potential of herbal\u2010derived active compounds as anti\u2010vitiligo drugs, as well as new drug delivery as a viable carrier and future possibilities to investigate.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jocd.15158","type":"journal-article","created":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T08:21:28Z","timestamp":1655194888000},"page":"5386-5404","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Drug delivery of natural products through nano\u2010carriers for effective vitiligo therapy: A compendia review"],"prefix":"10.1111","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7119-0847","authenticated-orcid":false,"given":"Abdul","family":"Qadir","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics School of Pharmaceutical Education and Research, Jamia Hamdard  New Delhi India"},{"name":"Department of Research and Developments Herbalfarm Health Care Private Limited  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shehla Nasar Mir Najib","family":"Ullah","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy, Faculty of Pharmacy King Khalid University  Abha Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2698-4637","authenticated-orcid":false,"given":"Samreen","family":"Jahan","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics School of Pharmaceutical Education and Research, Jamia Hamdard  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asad","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics School of Pharmaceutical Education and Research, Jamia Hamdard  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nausheen","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy and Phytochemistry, School of Pharmaceutical Education and Research Jamia Hamdard  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,6,25]]},"reference":[{"key":"e_1_2_16_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13671-017-0192-7"},{"key":"e_1_2_16_3_1","doi-asserted-by":"publisher","DOI":"10.4103\/0971-9903.189537"},{"issue":"3","key":"e_1_2_16_4_1","first-page":"1059","article-title":"Nanostructured lipid carrier system for the treatment for skin disease\u2014a review","volume":"5","author":"Upreti T","year":"2017","journal-title":"JSM Nanotechnol Nanomed"},{"key":"e_1_2_16_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-016-0167-9"},{"key":"e_1_2_16_6_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijd.IJD_344_18"},{"key":"e_1_2_16_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.11.061"},{"key":"e_1_2_16_8_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0749.2003.00032.x"},{"key":"e_1_2_16_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-008-0900-z"},{"key":"e_1_2_16_10_1","doi-asserted-by":"publisher","DOI":"10.1159\/000131485"},{"issue":"6","key":"e_1_2_16_11_1","first-page":"1529","article-title":"Mammalian tyrosinase\u2010related protein\u20101 is recognized by autoantibodies from vitiliginous Smyth chickens. An avian model for human vitiligo","volume":"146","author":"Austin LM","year":"1995","journal-title":"Am J Pathol"},{"key":"e_1_2_16_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2009.093278"},{"key":"e_1_2_16_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60763-7"},{"key":"e_1_2_16_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12291-010-0045-7"},{"key":"e_1_2_16_15_1","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.8976.1"},{"key":"e_1_2_16_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2010.03972.x"},{"key":"e_1_2_16_17_1","doi-asserted-by":"publisher","DOI":"10.4103\/0973-7847.65331"},{"key":"e_1_2_16_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-5945-8-2"},{"issue":"2","key":"e_1_2_16_19_1","first-page":"88","article-title":"Recent nanotechnological aspects in cosmetics and dermatological preparations","volume":"4","author":"Bangale MS","year":"2012","journal-title":"Int J Pharm Pharmaceut Sci"},{"key":"e_1_2_16_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.10.048"},{"key":"e_1_2_16_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.65"},{"key":"e_1_2_16_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2015.06.009"},{"key":"e_1_2_16_23_1","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.914898"},{"key":"e_1_2_16_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.152"},{"key":"e_1_2_16_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700340"},{"key":"e_1_2_16_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceca.2017.08.004"},{"key":"e_1_2_16_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15743"},{"key":"e_1_2_16_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.12949"},{"key":"e_1_2_16_29_1","doi-asserted-by":"publisher","DOI":"10.1159\/000506103"},{"key":"e_1_2_16_30_1","first-page":"13","volume-title":"Epidemiology, Definitions and Classification. In Vitiligo","author":"Ta\u00efeb A","year":"2010"},{"key":"e_1_2_16_31_1","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-15-51"},{"key":"e_1_2_16_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-148X.2012.00997.x"},{"key":"e_1_2_16_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2010.01328.x"},{"key":"e_1_2_16_34_1","doi-asserted-by":"publisher","DOI":"10.31782\/IJCRR.2020.12212"},{"key":"e_1_2_16_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.529"},{"key":"e_1_2_16_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.10.032"},{"key":"e_1_2_16_37_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aam7710"},{"key":"e_1_2_16_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2018.09.011"},{"key":"e_1_2_16_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2010.01847.x"},{"key":"e_1_2_16_40_1","doi-asserted-by":"publisher","DOI":"10.1348\/000711299160077"},{"key":"e_1_2_16_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2017.10.046"},{"key":"e_1_2_16_42_1","doi-asserted-by":"publisher","DOI":"10.4103\/0973-8398.72115"},{"key":"e_1_2_16_43_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.2012.686490"},{"key":"e_1_2_16_44_1","doi-asserted-by":"publisher","DOI":"10.3109\/10717544.2014.935532"},{"key":"e_1_2_16_45_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.7b00099"},{"key":"e_1_2_16_46_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-019-0514-y"},{"key":"e_1_2_16_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-48391-2_13"},{"key":"e_1_2_16_48_1","doi-asserted-by":"publisher","DOI":"10.1021\/la302278q"},{"key":"e_1_2_16_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1773-2247(06)50017-6"},{"key":"e_1_2_16_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphotobiol.2017.07.007"},{"key":"e_1_2_16_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2016.06.136"},{"key":"e_1_2_16_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2018.12.055"},{"key":"e_1_2_16_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.22104"},{"key":"e_1_2_16_54_1","doi-asserted-by":"publisher","DOI":"10.3109\/1061186X.2015.1070855"},{"key":"e_1_2_16_55_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546630601028729"},{"key":"e_1_2_16_56_1","doi-asserted-by":"publisher","DOI":"10.1211\/jpp.61.04.0002"},{"key":"e_1_2_16_57_1","doi-asserted-by":"publisher","DOI":"10.3109\/08982100903161449"},{"key":"e_1_2_16_58_1","doi-asserted-by":"publisher","DOI":"10.1159\/000140228"},{"key":"e_1_2_16_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2010.03.008"},{"key":"e_1_2_16_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2012.08.011"},{"key":"e_1_2_16_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2012.05.008"},{"key":"e_1_2_16_62_1","doi-asserted-by":"publisher","DOI":"10.1081\/DDC-120025458"},{"key":"e_1_2_16_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.02.981"},{"key":"e_1_2_16_64_1","doi-asserted-by":"publisher","DOI":"10.1021\/acscentsci.6b00230"},{"key":"e_1_2_16_65_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2021.1844180"},{"key":"e_1_2_16_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2008.05.008"},{"key":"e_1_2_16_67_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05475.x"},{"key":"e_1_2_16_68_1","doi-asserted-by":"publisher","DOI":"10.3109\/08982100902788408"},{"key":"e_1_2_16_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2008.01.020"},{"key":"e_1_2_16_70_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-008-9124-y"},{"key":"e_1_2_16_71_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-008-9078-8"},{"key":"e_1_2_16_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2004.01.006"},{"key":"e_1_2_16_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2006.03.018"},{"key":"e_1_2_16_74_1","doi-asserted-by":"publisher","DOI":"10.1080\/10717540490280697"},{"key":"e_1_2_16_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2004.06.001"},{"key":"e_1_2_16_76_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.20898"},{"key":"e_1_2_16_77_1","doi-asserted-by":"publisher","DOI":"10.2174\/156720106778559010"},{"key":"e_1_2_16_78_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-009-9199-0"},{"key":"e_1_2_16_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2005.09.052"},{"key":"e_1_2_16_80_1","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6882-11-21"},{"key":"e_1_2_16_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-2797(97)00067-7"},{"key":"e_1_2_16_82_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2003.01207.x"},{"issue":"2","key":"e_1_2_16_83_1","first-page":"224","article-title":"Polypodium leucotomos\u2010an overview of basic investigative findings","volume":"15","author":"Berman B","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_16_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0923-1811(03)00042-2"},{"key":"e_1_2_16_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.11.676"},{"key":"e_1_2_16_86_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1989.tb02517.x"},{"key":"e_1_2_16_87_1","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2009.2779"},{"key":"e_1_2_16_88_1","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.3345"},{"key":"e_1_2_16_89_1","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/133.1.98"},{"key":"e_1_2_16_90_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12172"},{"key":"e_1_2_16_91_1","doi-asserted-by":"publisher","DOI":"10.3928\/23258160-20201202-08"},{"key":"e_1_2_16_92_1","doi-asserted-by":"publisher","DOI":"10.5812\/ircmj.4515"},{"key":"e_1_2_16_93_1","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6882-8-3"},{"key":"e_1_2_16_94_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2009.01252.x"},{"key":"e_1_2_16_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2018.10.421"},{"key":"e_1_2_16_96_1","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2015.3242"},{"issue":"3","key":"e_1_2_16_97_1","first-page":"116","article-title":"Flavonoids enhance melanogenesis in human melanoma cells","volume":"39","author":"Takekoshi S","year":"2014","journal-title":"Tokai J Exp Clin Med"},{"key":"e_1_2_16_98_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12192-020-01071-7"},{"key":"e_1_2_16_99_1","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.5161"},{"key":"e_1_2_16_100_1","doi-asserted-by":"publisher","DOI":"10.1271\/bbb.50635"},{"key":"e_1_2_16_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2012.01.012"},{"key":"e_1_2_16_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2016.06.010"},{"key":"e_1_2_16_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpc.2021.109033"},{"key":"e_1_2_16_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2014.05.003"},{"key":"e_1_2_16_105_1","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.5794"},{"key":"e_1_2_16_106_1","doi-asserted-by":"publisher","DOI":"10.3390\/medicines6020068"},{"key":"e_1_2_16_107_1","doi-asserted-by":"publisher","DOI":"10.1080\/08923973.2020.1835952"},{"key":"e_1_2_16_108_1","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2016.5107"},{"key":"e_1_2_16_109_1","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.b19-00319"},{"key":"e_1_2_16_110_1","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.b15-00331"},{"key":"e_1_2_16_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2017.06.005"},{"issue":"5","key":"e_1_2_16_112_1","first-page":"2665","article-title":"Potential anti\u2010vitiligo properties of cynarine extracted from Vernonia anthelmintica (L.) Willd","volume":"42","author":"Mamat N","year":"2018","journal-title":"Int J Mol Med"},{"key":"e_1_2_16_113_1","first-page":"10","article-title":"Melanogenic effects of maclurin are mediated through the activation of cAMP\/PKA\/CREB and p38 MAPK\/CREB signaling pathways","volume":"22","author":"Hwang YS","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"e_1_2_16_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2007.06.007"},{"key":"e_1_2_16_115_1","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.21793"},{"key":"e_1_2_16_116_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21103537"},{"key":"e_1_2_16_117_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26082150"},{"key":"e_1_2_16_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2008.03.021"},{"key":"e_1_2_16_119_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.04-1925fje"},{"key":"e_1_2_16_120_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2009.05.022"},{"key":"e_1_2_16_121_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202x.2004.23606.x"},{"key":"e_1_2_16_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fitote.2019.104416"},{"key":"e_1_2_16_123_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.15038"},{"key":"e_1_2_16_124_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.17654"},{"key":"e_1_2_16_125_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113439"},{"key":"e_1_2_16_126_1","first-page":"12","article-title":"Isolation and characterization of isofraxidin 7\u2010O\u2010(6\u2032\u2010Op\u2010Coumaroyl)\u2010\u03b2\u2010glucopyranoside from Artemisia capillaris Thunberg: a novel, nontoxic hyperpigmentation agent that is effective in vivo","volume":"24","author":"Yim SH","year":"2017","journal-title":"Evid Based Complement Alternat Med"},{"key":"e_1_2_16_127_1","doi-asserted-by":"publisher","DOI":"10.4196\/kjpp.2014.18.4.307"},{"key":"e_1_2_16_128_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2018.04.051"},{"key":"e_1_2_16_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1875-5364(18)30116-X"},{"key":"e_1_2_16_130_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2007.04.046"},{"key":"e_1_2_16_131_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2019.03.007"},{"key":"e_1_2_16_132_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41374-018-0126-4"},{"key":"e_1_2_16_133_1","unstructured":"AliA.Methods for treating vitiligo. US No. (2021) 11123390B2."},{"key":"e_1_2_16_134_1","unstructured":"PeicaiS.Medicinal Composition for Treating Childhood Vitiligo. CN No. 2016:105343195A."},{"key":"e_1_2_16_135_1","unstructured":"WilsonDT.Compositions and Methods for Treating Vitiligo. WO No. 2015:084875."},{"key":"e_1_2_16_136_1","unstructured":"MagilavyD.Treatment for Vitiligo. US Patent No. 2015:9034881."},{"key":"e_1_2_16_137_1","unstructured":"BacusS MoranD.Compositions and Methods for Treatment of vitiligo. US Patent No. 2015:0202187"},{"key":"e_1_2_16_138_1","unstructured":"HantashBM UbeidAA.Peptide Tyrosinase Activators. US Patent No. 2015:0152139."},{"key":"e_1_2_16_139_1","unstructured":"BacusS.Compositions and Methods for Treatment of Vitiligo. US Patent No. 2015:8946256"},{"key":"e_1_2_16_140_1","unstructured":"ShangJ LiaoS JinY TianX ZhaoG ZhouJ WangQ PangS inventors; SHANDONG RUNZE PHARMACEUTICALS Co Ltd assignee.Application of fluoxetine to treatment of depigmentation diseases. United States patent application US 14\/364 037. 2015.U.S. Patent Application US20150065580A1."},{"key":"e_1_2_16_141_1","unstructured":"KimHJ ParkWS KohHJ MinDJ ParkNH ParkPJ KimSN inventors; Amorepacific Corp assignee.Composition for preventing or treating poliosis or vitiligo comprising a pueraria genus plant extract or puerarin. United States patent US 8 901 088. 2014."},{"key":"e_1_2_16_142_1","unstructured":"MsikaP SaunoisA Leclere\u2010BienfaitS BaudoinC.Laboratoires Expanscience 2014.Vigna unguiculata seed extract and compositions containing same. U.S. Patent 8 840 939."},{"key":"e_1_2_16_143_1","unstructured":"LiottaS.BIOMED VENTURE Srl UNIPERSONALE Soc 2016.\u00a0Topical preparation containing ngf for inducing skin pigmentation and for the treatment of cutaneous dyschromias and vitiligo. U.S. Patent 9 402 906."},{"key":"e_1_2_16_144_1","unstructured":"FerreiraEQ.Pharmaceutical Composition on the Basis of Stachytarpheta sp. a Process for Obtaining the same and its use for Treating Vitiligo. US Patent No. 2013:20130287868."},{"key":"e_1_2_16_145_1","unstructured":"KimEK ShinJH BabithaS ReyesG Adeltrudes.A Pharmaceutical Composition Comprising Extract ofCassia alataas an Active Ingredient for Treatment of Vitiligo. KR No. 2011:0008609."},{"key":"e_1_2_16_146_1","unstructured":"KimEK ShinJH BabithaS ReyesG AdeltrudesA.A Pharmaceutical Composition Comprising Extract of Cassia occidentalis as an Active Ingredient for Treatment of Vitiligo. KR No. 2011:0008609."},{"key":"e_1_2_16_147_1","unstructured":"VidalK Blum\u2010SperisenS PhilippeD BallevreO BucheliP WangJ.Wolfberries and Skin Inflammation. EP No. 2010:2200624."},{"key":"e_1_2_16_148_1","unstructured":"PaleoRA RojasUJ.Natural Product in Cream with Anti\u2010vitiligo Therapeutic Properties. EP No. 2007:1747786"},{"key":"e_1_2_16_149_1","unstructured":"ZhaoH.Mileuna Inc 2003.Composition and method for the treatment of vitiligo. U.S. Patent Application 10\/244 859."},{"key":"e_1_2_16_150_1","unstructured":"BhadraR PalP RoyR DuttaAK.Process for the preparation of an extract from human placenta containing glycosphingolipids and endothelin\u2010like constituent peptides useful for the treatment of vitiligo. US Patent No. 1997:5690966."},{"key":"e_1_2_16_151_1","unstructured":"KimYC KangCH ParkEY KimSN.Keimyung University Industry\u2010Academic Cooperation Foundation 2014.Composition for treating vitiligo or canities comprising extract from sophora japonica as active ingredient. U.S. Patent 8 673 371."},{"key":"e_1_2_16_152_1","doi-asserted-by":"publisher","DOI":"10.3390\/gels7040209"}],"container-title":["Journal of Cosmetic Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jocd.15158","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jocd.15158","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jocd.15158","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:32:30Z","timestamp":1791495150000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jocd.15158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,25]]},"references-count":151,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["10.1111\/jocd.15158"],"URL":"https:\/\/doi.org\/10.1111\/jocd.15158","archive":["Portico"],"relation":{},"ISSN":["1473-2130","1473-2165"],"issn-type":[{"value":"1473-2130","type":"print"},{"value":"1473-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,25]]},"assertion":[{"value":"2022-04-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}